Alejandro Aranda

Title: Alejandro Aranda: Innovator in Neurogenic Detrusor Overactivity Treatment

Introduction

Alejandro Aranda is a notable inventor based in Pamplona, Spain. He has made significant contributions to the field of medical technology, particularly in the treatment of neurogenic detrusor overactivity (NDO). His innovative approach has led to the development of a unique pharmaceutical composition aimed at addressing this condition.

Latest Patents

Alejandro Aranda holds one patent titled "Viral vectors for treating neurogenic detrusor overactivity." This invention provides a method and a pharmaceutical composition for treating NDO. It involves a viral expression vector that carries a transcription cassette harboring transgene(s) that inhibit or silence neurotransmission or synaptic transmission of afferent neurons. This groundbreaking work has the potential to improve the quality of life for individuals suffering from this condition.

Career Highlights

Throughout his career, Alejandro has worked with esteemed institutions such as Université de Versailles-St Quentin-en-Yvelines and Assistance Publique-Hôpitaux de Paris. His experience in these organizations has allowed him to collaborate with leading experts in the field and further his research in neurogenic detrusor overactivity.

Collaborations

Alejandro has collaborated with notable professionals, including François Giuliano and Alberto Epstein. These partnerships have enriched his research and contributed to the advancement of his innovative work.

Conclusion

Alejandro Aranda is a distinguished inventor whose work in the treatment of neurogenic detrusor overactivity showcases his commitment to medical innovation. His contributions have the potential to make a significant impact in the field of healthcare.